Influence of food on absorption of erythromycin ethyl succinate.

Antimicrobial Agents and Chemotherapy
P J ThompsonG E Marlin

Abstract

Erythromycin plasma concentrations were determined in 18 subjects after a single dose (800 mg) of a new formulation of erythromycin ethyl succinate taken immediately before, immediately after, and 1 h after food. Adequate absorption occurred with all treatments, although bioavailability was best when the drug was taken before food. Absorption was delayed by food, with the highest and earliest peak plasma erythromycin levels occurring under fasting conditions.

References

Jun 1, 1977·Australian and New Zealand Journal of Medicine·W G Cooksley, L W Powell
Oct 1, 1979·British Journal of Clinical Pharmacology·J RutlandG E Marlin
Apr 1, 1978·Journal of Clinical Pharmacology·T C CoyneH C Shirkey
Jun 1, 1978·Journal of Pharmaceutical Sciences·P G WellingL L Lyons
Oct 1, 1977·Journal of Clinical Pharmacology·P J McDonaldM J Story
Jan 1, 1969·Applied Microbiology·S C BellW E Grundy
Jan 1, 1964·The American Journal of the Medical Sciences·R S GRIFFITH, H R BLACK

❮ Previous
Next ❯

Citations

Jul 3, 2002·Drugs·Lars E Schmidt, Kim Dalhoff
Mar 19, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Mouna Cheikh Rouhou, Sami Haddad
Oct 24, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Mouna Cheikh RouhouSami Haddad
Sep 27, 2005·The British Journal of Dermatology·S NatarajanR J Koerner
May 28, 2019·The Cochrane Database of Systematic Reviews·Diana Buitrago-GarciaRodrigo Pardo
Nov 18, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M-A VernerS Haddad

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.